Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Coeur Mining, Inc (NYSE: CDE): Production Surge, Cash Flow Expansion Reshape Valuation Outlook

Coeur Mining, Inc. reported a record operational and financial performance in the fourth quarter of 2025, capping a transformative year marked by significant production growth, stronger margins, and improved liquidity.

Vinay Lochav | 09 March 2026

The Oil Chart the World Will Study for Decades

There are sessions that traders forget by the following Monday. And then there are sessions that get printed in textbooks. March 9, 2026 belongs firmly in the second category. In the span of a single trading day, Brent crude — the global benchmark for …

Nitish Kishor | 09 March 2026

U.S. Antimony Corporation (NYSE: UAMY) Bets on Critical Minerals Boom Despite Earnings Miss

The global race to secure critical minerals has intensified as governments seek to strengthen supply chains for defense systems, renewable energy technologies, and advanced electronics. Materials once considered obscure are now central to industrial policy and national security planning.

Vinay Lochav | 09 March 2026

Tigo Energy Inc (NASDAQ: TYGO) Expands Solar Technology Platform as Revenue Surges

The global energy transition continues to reshape the power sector as governments, utilities, and businesses accelerate the adoption of renewable energy. Solar installations have expanded rapidly across residential, commercial, and utility scale markets, supported by falling equipment costs and supportive policy frameworks.

Vinay Lochav | 09 March 2026

TTM Technologies Inc (NASDAQ: TTMI) Rides AI and Defense Demand to Record Earnings

The semiconductor and electronics supply chain is undergoing structural change as artificial intelligence, cloud computing, and defense modernization reshape demand for high-performance electronic components. At the center of these technological shifts are advanced printed circuit boards and integrated electronics modules that enable increasingly complex …

Vinay Lochav | 09 March 2026

TRX Gold Corporation (NYSE: TRX) Advances Buckreef Expansion as Strong Gold Prices Support Cash Flow Growth

The global gold market has entered a period of renewed strength as investors respond to persistent inflation risks, geopolitical uncertainty, and evolving monetary policy expectations. In such an environment, gold mining companies with operating assets and expansion potential are positioned to benefit from higher …

Vinay Lochav | 09 March 2026

PAR Technology Corporation (NYSE: PAR) Expands AI Platform as Recurring Revenue Growth Accelerates

Digital transformation in the restaurant industry is accelerating as operators seek technology platforms that improve efficiency, customer engagement, and profitability. Rising labor costs, tighter margins, and the expansion of digital ordering have forced restaurant chains to invest heavily in integrated technology systems.

Vinay Lochav | 09 March 2026

Opendoor Technologies Inc (NASDAQ: OPEN) Turnaround Strategy Gains Momentum as AI and Product Changes Reshape iBuying Model

The U.S. residential real estate market has long been characterized by complex transactions, fragmented services, and a reliance on intermediaries. Digital real estate platforms have attempted to modernize this process by using technology to simplify buying and selling homes.

Vinay Lochav | 09 March 2026

Ciena Corporation (NYSE: CIEN) Record Revenue Signals AI Connectivity Boom as Optical Demand Surges

Global data infrastructure is entering a new phase of expansion driven by artificial intelligence workloads, hyperscale cloud computing, and the proliferation of large-scale data centers. These trends require massive upgrades in high-capacity networking systems capable of transporting data across cities, regions, and continents.

Vinay Lochav | 09 March 2026

Zura Bio Limited’s (NASDAQ: ZURA) Immunology Bet: Can Dual-Pathway Antibodies Unlock the Next Wave of Autoimmune Therapies?

Biotechnology investors increasingly view immunology as one of the most promising frontiers in drug development. Advances in antibody engineering, deeper understanding of inflammatory pathways, and growing demand for therapies targeting chronic autoimmune conditions have created a fertile environment for emerging biotechnology companies.

Vinay Lochav | 09 March 2026
Support

Hi! How can we help you today?

Loading…